News
Events
- April 23, 2021 Lidings Partner Alexander Popelyuk Speaks at RAA Conference on Collecting Bad Debts
- April 16, 2021 Lidings Partner Alexander Popelyuk Speaks at Forbes’ Bankruptcy Conference
- April 15, 2021 Lidings Partner Boris Malakhov Speaks at Intellectual Property Conference in Moscow
- April 13-14, 2021 Lidings Partner Stepan Guzey Takes Part in Virtual Arbitration & Fraud in Russia & CIS Conference
Recent Deals
Representing Japanese pharmaceutical company Santen in a dispute on debt recovery with a Russian distributor of medicines
Advising major international pharmaceuticals company Glenmark on several compliance issues, advertising law and activities aimed at promoting medical products on the Internet
Advising Japanese electronics company Sharp in a dispute with the Federal Tax Service (FTS) on the issue related to preliminary classification of a product and supplemental tax assessment
Legal support of the fund established by inheritors of the famous Tove Jansson in monitoring online and offline infringements and protecting their copyrights to Moomin characters in Russia
The Eurasian Patent Office has launched the Pharmaceutical Register
On 1 March 2021, the Eurasian Patent Office (EAPO) has launched the Pharmaceutical Register containing information on drugs and relevant Eurasian patents. Similar registers have long been set up worldwide to settle disputes between patent holders and generic producers. The Register will certainly impact Russian practice
Legal Digest | Pharmaceutical Antitrust Disputes
Heaving vast expertise in providing legal protection to large Russian and international pharmaceuticals and healthcare companies, Lidings has put together a Legal Digest highlighting the most notable antitrust disputes in pharma in 2019
Legal Digest | September 2020: Patent Disputes in Life Sciences (EAEU, CIS, Eastern Europe)
Heaving vast expertise in providing legal protection to large Russian and international pharmaceuticals and healthcare companies, Lidings has put together a Legal Digest highlighting the most notable patents disputes in Life Sciences
